» Articles » PMID: 36856750

Recent Progress and Challenges in the Treatment of Spinal Cord Injury

Overview
Journal Protein Cell
Date 2023 Mar 1
PMID 36856750
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) disrupts the structural and functional connectivity between the higher center and the spinal cord, resulting in severe motor, sensory, and autonomic dysfunction with a variety of complications. The pathophysiology of SCI is complicated and multifaceted, and thus individual treatments acting on a specific aspect or process are inadequate to elicit neuronal regeneration and functional recovery after SCI. Combinatory strategies targeting multiple aspects of SCI pathology have achieved greater beneficial effects than individual therapy alone. Although many problems and challenges remain, the encouraging outcomes that have been achieved in preclinical models offer a promising foothold for the development of novel clinical strategies to treat SCI. In this review, we characterize the mechanisms underlying axon regeneration of adult neurons and summarize recent advances in facilitating functional recovery following SCI at both the acute and chronic stages. In addition, we analyze the current status, remaining problems, and realistic challenges towards clinical translation. Finally, we consider the future of SCI treatment and provide insights into how to narrow the translational gap that currently exists between preclinical studies and clinical practice. Going forward, clinical trials should emphasize multidisciplinary conversation and cooperation to identify optimal combinatorial approaches to maximize therapeutic benefit in humans with SCI.

Citing Articles

Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases.

Li H, Zhang P, Lin M, Li K, Zhang C, He X Stem Cell Res Ther. 2025; 16(1):68.

PMID: 39940049 PMC: 11816542. DOI: 10.1186/s13287-025-04167-y.


Targeting the sigma-1 receptor with pridopidine induces functional neurorestoration in spinal cord ischemia-reperfusion injury.

Sweed E, Khodir S, Motawea S, El-Haron H, Mostafa B, Elkholy M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39937253 DOI: 10.1007/s00210-025-03851-3.


Multi-targeted nanogel drug delivery system alleviates neuroinflammation and promotes spinal cord injury repair.

Wang P, Chen Z, Li P, Al Mamun A, Ning S, Zhang J Mater Today Bio. 2025; 31:101518.

PMID: 39935893 PMC: 11810842. DOI: 10.1016/j.mtbio.2025.101518.


Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.

Mou C, Xia Z, Wang X, Dai X, Wang J, Zhang C Front Neurol. 2025; 16:1447414.

PMID: 39926016 PMC: 11802430. DOI: 10.3389/fneur.2025.1447414.


Natural polymer based drug-loaded hydrogel platform for comprehensive care of acute spinal cord injury.

Zhang M, Xiang C, Zhen X, Luo W, He X, Guo F Mater Today Bio. 2025; 31:101464.

PMID: 39896281 PMC: 11783013. DOI: 10.1016/j.mtbio.2025.101464.


References
1.
Watkins T, Wang B, Huntwork-Rodriguez S, Yang J, Jiang Z, Eastham-Anderson J . DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury. Proc Natl Acad Sci U S A. 2013; 110(10):4039-44. PMC: 3593899. DOI: 10.1073/pnas.1211074110. View

2.
Alvarez Z, Kolberg-Edelbrock A, Sasselli I, Ortega J, Qiu R, Syrgiannis Z . Bioactive scaffolds with enhanced supramolecular motion promote recovery from spinal cord injury. Science. 2021; 374(6569):848-856. PMC: 8723833. DOI: 10.1126/science.abh3602. View

3.
Griffin J, Bradke F . Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem. EMBO Mol Med. 2020; 12(3):e11505. PMC: 7059014. DOI: 10.15252/emmm.201911505. View

4.
Wang X, Yigitkanli K, Kim C, Sekine-Komo T, Wirak D, Frieden E . Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion. J Neurotrauma. 2014; 31(24):1955-66. PMC: 4245872. DOI: 10.1089/neu.2014.3355. View

5.
Stern S, Hilton B, Burnside E, Dupraz S, Handley E, Gonyer J . RhoA drives actin compaction to restrict axon regeneration and astrocyte reactivity after CNS injury. Neuron. 2021; 109(21):3436-3455.e9. DOI: 10.1016/j.neuron.2021.08.014. View